Plaque Rupture in a Hodgkin Lymphoma Survivor Without Cardiovascular Risk Factors 20 Years After Thoracic Radiotherapy: A Case Report

Overview

Journal J Cardiovasc Dev Dis

Specialty Cardiology & Vascular Diseases

Date 2023 Aug 25

PMID 37623337

Authors

Elissa A S Polomski

Michiel A de Graaf

J Wouter Jukema

M Louisa Antoni

Affiliations

Soon will be listed here.

Abstract

Background: Major improvements in cancer therapies have significantly contributed to increased survival rates of Hodgkin lymphoma (HL) survivors, outweighing cardiovascular side effects and the risks of radiation-induced heart disease. Non-invasive screening for coronary artery disease (CAD) starting five years after irradiation is recommended, as plaque development and morphology may differ in this high-risk population. Due to rapid plaque progression and a possibly higher incidence of non-calcified plaques, coronary artery calcium scoring may not be sufficient as a screening modality in HL survivors treated with thoracic radiotherapy.

Case Summary: A 42-year-old man with a history of HL treated with thoracic radiotherapy presented at the emergency department 20 years after cancer treatment with an ST-elevation myocardial infarction, in the absence of cardiovascular risk factors, for which primary percutaneous coronary intervention of the left anterior descending artery was performed. Four months prior to acute myocardial infarction, invasive coronary angiography only showed wall irregularities. Two years earlier, the Agatston calcium score was zero.

Discussion: In HL survivors treated with thoracic radiotherapy, a calcium score of zero may not give the same warranty period for cardiac event-free survival compared to the general population. Coronary computed tomography angiography can be a proper diagnostic tool to detect CAD at an early stage after mediastinal irradiation, as performing calcium scoring may not be sufficient in this population to detect non-calcified plaques, which may show rapid progression and lead to acute coronary syndrome. Also, intensive lipid-lowering therapy should be considered in the presence of atherosclerosis in this patient population.

References

Gyenes G, Fornander T, Carlens P, Glas U, Rutqvist L . Detection of radiation-induced myocardial damage by technetium-99m sestamibi scintigraphy. Eur J Nucl Med. 1997; 24(3):286-92. DOI: 10.1007/BF01728765. View

Kupeli S, Hazirolan T, Varan A, Akata D, Alehan D, Hayran M . Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma. J Clin Oncol. 2009; 28(6):1025-30. DOI: 10.1200/JCO.2009.25.2627. View

Lopez-Mattei J, Yang E, Baldassarre L, Agha A, Blankstein R, Choi A . Cardiac computed tomographic imaging in cardio-oncology: An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT). Endorsed by the International Cardio-Oncology Society (ICOS). J Cardiovasc Comput Tomogr. 2022; 17(1):66-83. DOI: 10.1016/j.jcct.2022.09.002. View

Delaney G, Jacob S, Featherstone C, Barton M . The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer. 2005; 104(6):1129-37. DOI: 10.1002/cncr.21324. View

Parker M, Iskandar A, Limone B, Perugini A, Kim H, Jones C . Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis. Circ Cardiovasc Imaging. 2012; 5(6):700-7. DOI: 10.1161/CIRCIMAGING.112.978270. View

de Jong M, Genders T, van Geuns R, Moelker A, Hunink M . Diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: a systematic review and meta-analysis. Eur Radiol. 2012; 22(9):1881-95. PMC: 3411304. DOI: 10.1007/s00330-012-2434-1. View

Chung E, Corbett J, Moran J, Griffith K, Marsh R, Feng M . Is there a dose-response relationship for heart disease with low-dose radiation therapy?. Int J Radiat Oncol Biol Phys. 2012; 85(4):959-64. PMC: 5175458. DOI: 10.1016/j.ijrobp.2012.08.002. View

de Geus-Oei L, Mavinkurve-Groothuis A, Bellersen L, Gotthardt M, Oyen W, Kapusta L . Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity. J Nucl Med. 2011; 52(4):560-71. DOI: 10.2967/jnumed.110.082784. View

Hancock S, Donaldson S, Hoppe R . Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol. 1993; 11(7):1208-15. DOI: 10.1200/JCO.1993.11.7.1208. View

10.

Li J, Montarello N, Hoogendoorn A, Verjans J, Bursill C, Peter K . Multimodality Intravascular Imaging of High-Risk Coronary Plaque. JACC Cardiovasc Imaging. 2021; 15(1):145-159. DOI: 10.1016/j.jcmg.2021.03.028. View

11.

ORourke R, Brundage B, Froelicher V, Greenland P, Grundy S, Hachamovitch R . American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol. 2000; 36(1):326-40. DOI: 10.1016/s0735-1097(00)00831-7. View

12.

Lyon A, Lopez-Fernandez T, Couch L, Asteggiano R, Aznar M, Bergler-Klein J . 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J Cardiovasc Imaging. 2022; 23(10):e333-e465. DOI: 10.1093/ehjci/jeac106. View

13.

Correa C, Litt H, Hwang W, Ferrari V, Solin L, Harris E . Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J Clin Oncol. 2007; 25(21):3031-7. DOI: 10.1200/JCO.2006.08.6595. View

14.

Danad I, Raijmakers P, Driessen R, Leipsic J, Raju R, Naoum C . Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve. JAMA Cardiol. 2017; 2(10):1100-1107. PMC: 5710451. DOI: 10.1001/jamacardio.2017.2471. View

15.

Mulrooney D, Yeazel M, Kawashima T, Mertens A, Mitby P, Stovall M . Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009; 339:b4606. PMC: 3266843. DOI: 10.1136/bmj.b4606. View

16.

Haddy N, Diallo S, El-Fayech C, Schwartz B, Pein F, Hawkins M . Cardiac Diseases Following Childhood Cancer Treatment: Cohort Study. Circulation. 2015; 133(1):31-8. DOI: 10.1161/CIRCULATIONAHA.115.016686. View

17.

Marks L, Yu X, Prosnitz R, Zhou S, Hardenbergh P, Blazing M . The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys. 2005; 63(1):214-23. DOI: 10.1016/j.ijrobp.2005.01.029. View

18.

Heidenreich P, Schnittger I, Strauss H, Vagelos R, Lee B, Mariscal C . Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol. 2006; 25(1):43-9. DOI: 10.1200/JCO.2006.07.0805. View

19.

Lancellotti P, Nkomo V, Badano L, Bergler-Klein J, Bogaert J, Davin L . Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2013; 14(8):721-40. DOI: 10.1093/ehjci/jet123. View

20.

Gould K, Johnson N, Bateman T, Beanlands R, Bengel F, Bober R . Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol. 2013; 62(18):1639-1653. DOI: 10.1016/j.jacc.2013.07.076. View